A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia
Clinical trial NCT02251548 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02251548
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2025-01-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.